DIA 2024 - Redefining Excellence in Managing Patient Recruitment and Remote Data Collection
Image

Adaptive Optics Retinal Imaging

Recruiting
12 - 120 years of age
Both
Phase N/A

Powered by AI

Overview

Background
  • By the time diseases of the retina are detected, serious damage has often already been done. Researchers want to find better ways of viewing the retina. One way called adaptive optics may help detect problems earlier.
    Objectives
  • To study if adaptive optics can help find better ways to diagnose, treat, and manage retinal diseases.
    Eligibility
  • People over age 12 with an eye disease.
  • Healthy volunteers over age 12.
    Design
  • Participants will be screened with medical history and eye exams. These may include dilating pupils and taking pictures of the eyes.
  • Participants will have 1 or more study visits. They will have:
  • Medical and eye history.
  • Questions about their medications.
  • Eye exam including pupil dilation.
  • Adaptive optics imaging. After dilation, participants sit still while looking into an adaptive optics instrument. They look at specific places and images are taken of their retina.
  • They may also have:
  • More images.
  • Perimetry. Participants look into a lens and press a button when they see a light.
  • Color vision tests.
  • Electroretinogram. Participants will get numbing eye drops and special contact lenses. A small metal electrode will be put on their forehead. They will look at flashing lights and try not to blink.

Description

Objective: The objective of this protocol is to collect and assess adaptive optics (AO) retinal images of normal and diseased eyes.

Study Population: Three hundred and fifty (350) participants with eye diseases and 250 normal volunteers will be enrolled.

Design: This is an observational protocol which will enroll 350 participants with various eye diseases and 250 age-matched healthy volunteers over five years. In general, participants will undergo a complete ophthalmic examination including assessments of visual acuity, intraocular pressure, and a dilated ocular examination. Imaging will be performed using adaptive optics instruments deployed in the NEI Eye Clinic.

Outcome Measures: The primary outcome for this protocol is qualitative and quantitative assessment of the AO images with comparisons of normal and diseased states.

Eligibility

  • INCLUSION CRITERIA:

Participants will be eligible if they:

  • Are 12 years of age or older.
  • Have the ability to cooperate with an eye exam and adaptive optics imaging.
  • Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children.
  • Have an eye disease or are a healthy volunteer with a normal eye exam (no visually-significant eye findings on examination).

EXCLUSION CRITERIA:

Participants will not be eligible if:

        -They have a condition which prevents adequate images from being obtained (e.g. unstable
        fixation or media opacity).
        EXCLUSION CRITERIA FOR FLUORESCEIN AND/OR INDOCYANINE GREEN IMAGING
        Partaicipants are not eligible for fluorescein and/or indocyanine green imaging if they:
          -  Are under 18 years of age.
          -  For participants who will undergo fluorescein imaging have a history of adverse
             reaction to fluorescein.
          -  For participants who will undergo indocyanine green imaging have a history of adverse
             reaction to indocyanine green dye, know or suspected allergies to iodine or shellfish.

Study details

Eye Diseases, Healthy Volunteers

NCT02317328

National Eye Institute (NEI)

8 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.